Global Acute Myeloid Leukemia (AML) Therapeutics Market Research Report 2023

Global Acute Myeloid Leukemia (AML) Therapeutics Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Radiation therapy
1.2.4 Stem Cell Transplant
1.2.5 Targeted Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Perspective (2018-2029)
2.2 Acute Myeloid Leukemia (AML) Therapeutics Growth Trends by Region
2.2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acute Myeloid Leukemia (AML) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Acute Myeloid Leukemia (AML) Therapeutics Market Dynamics
2.3.1 Acute Myeloid Leukemia (AML) Therapeutics Industry Trends
2.3.2 Acute Myeloid Leukemia (AML) Therapeutics Market Drivers
2.3.3 Acute Myeloid Leukemia (AML) Therapeutics Market Challenges
2.3.4 Acute Myeloid Leukemia (AML) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia (AML) Therapeutics Revenue
3.4 Global Acute Myeloid Leukemia (AML) Therapeutics Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia (AML) Therapeutics Revenue in 2022
3.5 Acute Myeloid Leukemia (AML) Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia (AML) Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia (AML) Therapeutics Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia (AML) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Type (2024-2029)
5 Acute Myeloid Leukemia (AML) Therapeutics Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia (AML) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acute Myeloid Leukemia (AML) Therapeutics Market Size (2018-2029)
6.2 North America Acute Myeloid Leukemia (AML) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023)
6.4 North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size (2018-2029)
7.2 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023)
7.4 Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size (2018-2029)
9.2 Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Introduction
11.1.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Acute Myeloid Leukemia (AML) Therapeutics Introduction
11.2.4 Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Acute Myeloid Leukemia (AML) Therapeutics Introduction
11.3.4 Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Genmab
11.4.1 Genmab Company Detail
11.4.2 Genmab Business Overview
11.4.3 Genmab Acute Myeloid Leukemia (AML) Therapeutics Introduction
11.4.4 Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
11.4.5 Genmab Recent Development
11.5 GlaxoSmithKline Pharmaceuticals
11.5.1 GlaxoSmithKline Pharmaceuticals Company Detail
11.5.2 GlaxoSmithKline Pharmaceuticals Business Overview
11.5.3 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Introduction
11.5.4 GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
11.5.5 GlaxoSmithKline Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Stem Cell Transplant
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Others
Table 7. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Region (2018-2023)
Table 11. Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Region (2024-2029)
Table 13. Acute Myeloid Leukemia (AML) Therapeutics Market Trends
Table 14. Acute Myeloid Leukemia (AML) Therapeutics Market Drivers
Table 15. Acute Myeloid Leukemia (AML) Therapeutics Market Challenges
Table 16. Acute Myeloid Leukemia (AML) Therapeutics Market Restraints
Table 17. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia (AML) Therapeutics as of 2022)
Table 20. Ranking of Global Top Acute Myeloid Leukemia (AML) Therapeutics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Acute Myeloid Leukemia (AML) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Myeloid Leukemia (AML) Therapeutics Product Solution and Service
Table 24. Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Type (2024-2029)
Table 30. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Application (2024-2029)
Table 34. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bristol-Myers Squibb Company Detail
Table 50. Bristol-Myers Squibb Business Overview
Table 51. Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Product
Table 52. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Bristol-Myers Squibb Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Acute Myeloid Leukemia (AML) Therapeutics Product
Table 57. Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Roche Company Detail
Table 60. Roche Business Overview
Table 61. Roche Acute Myeloid Leukemia (AML) Therapeutics Product
Table 62. Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Roche Recent Development
Table 64. Genmab Company Detail
Table 65. Genmab Business Overview
Table 66. Genmab Acute Myeloid Leukemia (AML) Therapeutics Product
Table 67. Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Genmab Recent Development
Table 69. GlaxoSmithKline Pharmaceuticals Company Detail
Table 70. GlaxoSmithKline Pharmaceuticals Business Overview
Table 71. GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Product
Table 72. GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023) & (US$ Million)
Table 73. GlaxoSmithKline Pharmaceuticals Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Features
Figure 4. Radiation therapy Features
Figure 5. Stem Cell Transplant Features
Figure 6. Targeted Therapy Features
Figure 7. Others Features
Figure 8. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Acute Myeloid Leukemia (AML) Therapeutics Report Years Considered
Figure 14. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Region: 2022 VS 2029
Figure 17. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Players in 2022
Figure 18. Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia (AML) Therapeutics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia (AML) Therapeutics Revenue in 2022
Figure 20. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2018-2029)
Figure 22. United States Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2018-2029)
Figure 26. Germany Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Share by Region (2018-2029)
Figure 34. China Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2018-2029)
Figure 42. Mexico Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2018-2029)
Figure 46. Turkey Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
Figure 50. Roche Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
Figure 51. Genmab Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
Figure 52. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029

Published: 11-Jan-2024        Price: US 5600 Onwards        Pages: 177

The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029. The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022. The market research report offered here is a v......

Global Digital Watermark Technology Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029. North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029. Asia-Pacific market for Digital Watermark Technol......

Global Location Based Marketing Services Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030. North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Location Based Marketing Services is estima......

Global Auto Repair and Beauty Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 72

The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......

Global Viral Vector Development Service Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Viral Vector Development Service is estimated to increase from......

Global Building Automation Systems (BAS) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030. North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Building Automation Systems (BAS) is estimat......

Global SLAM in Mobile Robots and Smart AR Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92

This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......

Global Digital Educational Publishing Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030. North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Digital Educational Publishing is estimated to inc......

Global Human Source Service Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs